Importance of Pediatric Biopharmaceutics in Design and Manufacture of Pediatric Dose Forms
Summary: Over the years, tremendous efforts have been made by regulators to encourage pharmaceutical companies to develop pediatric medicines. However, developing drug products in pediatric populations can be a challenge due to the physiological differences between children and adults. This complexity is further compounded with the requirement of age appropriate dosage forms.
Join this webcast to hear a recognised expert discuss the current challenges in pediatric drug development programs including predicting oral absorption, and in vitro and in silico methods that can be applied to predict behavior in pediatric populations. During this session, a Catalent expert will highlight formulation and dosage form development strategies based on target product profiles that can help bring patient centered treatments faster to market.